![Robin Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robin Li
Oprichter bij Biomap (Beijing) Intelligent Technology Co., Ltd.
Profiel
Robin Li is the founder of BioMap, Inc. He is also the Chairman of Biomap (Beijing) Intelligent Technology Co., Ltd.
since 2020.
Actieve functies van Robin Li
Bedrijven | Functie | Begin |
---|---|---|
Biomap (Beijing) Intelligent Technology Co., Ltd.
![]() Biomap (Beijing) Intelligent Technology Co., Ltd. Information Technology ServicesTechnology Services Biomap (Beijing) Intelligent Technology Co., Ltd. is a Chinese biotech company founded in 2020 by Robin Li and Wei Liu. The company is based in Beijing, China and is the first biocomputing-driven biotech company in China. Biomaps' technology, Xtrimo, is a protein-centric large language model platform that allows scientists to model life more accurately, from proteins to a system level, and extract novel insights and predictions from limited data. The company's mission is to leverage AI and data to radically improve patients' lives by accelerating the R&D process of early screening/diagnosis, drug discovery, and other precision medicine products. Biomaps' focus is on building their internal AI engine and data collection capabilities to curate their proprietary insights for difficult diseases. The company is a startup biotech company aiming to accelerate novel drug discovery for unmet medical needs. Wei Liu has been the CEO since 2020. | Oprichter | 01-11-2020 |
BioMap, Inc. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Biomap (Beijing) Intelligent Technology Co., Ltd.
![]() Biomap (Beijing) Intelligent Technology Co., Ltd. Information Technology ServicesTechnology Services Biomap (Beijing) Intelligent Technology Co., Ltd. is a Chinese biotech company founded in 2020 by Robin Li and Wei Liu. The company is based in Beijing, China and is the first biocomputing-driven biotech company in China. Biomaps' technology, Xtrimo, is a protein-centric large language model platform that allows scientists to model life more accurately, from proteins to a system level, and extract novel insights and predictions from limited data. The company's mission is to leverage AI and data to radically improve patients' lives by accelerating the R&D process of early screening/diagnosis, drug discovery, and other precision medicine products. Biomaps' focus is on building their internal AI engine and data collection capabilities to curate their proprietary insights for difficult diseases. The company is a startup biotech company aiming to accelerate novel drug discovery for unmet medical needs. Wei Liu has been the CEO since 2020. | Technology Services |
BioMap, Inc. |